Scientists have long known that artificial light can impact the behavior of animals. Now, they've discovered that light can increase foraging time in black birds.
It's unfortunately true. Most of us prefer junk food over healthier food choices, but is it simply because they taste better?
When it comes to sexual preference, our culture idealizes feminine women and masculine men. Yet a new study shows that that instead of a long process of social and sexual selection, this preference may be a relatively new habit that has emerged in modern, urbanized societies.
Researchers at the Imperial College London may have discovered a solution to chronic diarrhea-what's otherwise referred to as bile acid diarrhea (BAD) and oftentimes mistaken for irritable bowel syndrome (IBS) by many doctors throughout the world. As statistics show that about one in 100 adults in w...
Infection of the herpes simplex virus may increase the risk of Alzheimer's disease, according to a recent study conducted by researchers at Umea University.
It turns out that improving access to electricity won't up a nation's total carbon emissions growth to a large extent.
Our birth month may ultimately determine if we're more likely to be at risk for certain mood disorders, according to findings that will be presented at the European College of CNP Congress in Berlin.
Children with the enterovirus infection are about 50 percent more likely to develop type 1 diabetes, according to recent findings published in the journal Diabetologia.
Men with low testosterone may often experience low sex drive and depleted muscle mass. Yet recent findings published in the Journal of Clinical Endocrinology & Metabolism show us that diabetic men with low testosterone are also at a higher risk for certain heart problems.
Scientists may have discovered a cure for "love handles." You heard right!
New findings published in JAMA Dermatology suggest that those suffering from psoriasis could be at an increased risk of high blood pressure, as well.
The Food and Drug Administration (FDA) has just approved an antiviral drug in patients who have Ebola. The North Carolina drug maker, Chimerix, received clearance Thursday on how to proceed with a trial examining the safety and effectiveness of brincidofovir tablets in patients with the virus.